1061results about How to "Suppression problem" patented technology

A stent for application within an aneurysm the stent comprising an elongated tubular member having a proximal end and a distal end. The stent has a proximal portion expandable from a first diameter to a second diameter. The distal end of the stent may be expandable to a third diameter, which third diameter is larger than the second diameter. The stent may be left disposed across the neck of the aneurysm.

Implantable medical device eluting drug locally and in prolonged period is provided, including several types of such a device, the treatment modes of implementation and methods of implantation. The device comprising of polymeric substrate, such as a matrix for example, that is used as the device body, and drugs, and in some cases additional scaffolding materials, such as metals or additional polymers, and materials to enhance visibility and imaging. The selection of drug is based on the advantageous of releasing drug locally and in prolonged period, where drug is released directly to the extracellular matrix (ECM) of the diseased area such as tumor, inflammation, degeneration or for symptomatic objectives, or to injured smooth muscle cells, or for prevention. One kind of drug is the gene silencing drugs based on RNA interference (RNAi), including but not limited to si RNA, sh RNA, or antisense RNA/DNA, ribozyme and nucleoside analogs. The modes of implantation in some embodiments are existing implantation procedures that are developed and used today for other treatments, including brachytherapy and needle biopsy. In such cases the dimensions of the new implant described in this invention are similar to the original implant. Typically a few devices are implanted during the same treatment procedure.

A tiled display apparatus includes at least five functionally identical transparent partially-overlapped display tiles arranged in two dimensions, each display tile including pixels arranged in a two-dimensional array, and the display tiles being disposed so that light emitted by pixels located beneath a neighboring display tile at the edge of the pixel array passes through the neighboring display tile.

Systems and methods for detecting a respiration signal in a target area are disclosed. Briefly described, in architecture, one embodiment of the system, among others, can be implemented as follows. The system includes a scanning antenna configured to transmit a microwave signal across a horizontal axis in the target area. Also, the system includes a control system that tracks the position of the scanning antenna along the horizontal axis. A signal processing system then detects a respiration signal of a living subject in the target area from reflected microwave signals from the target area and the positional data. Other systems and methods are also provided.

A dietary supplement for benefitting human bone health includes a calcium source, a source of vitamin D activity, and an osteoblast stimulant. A preferred calcium source is microcrystalline hydroxyapatite, which also contains protein (mostly collagen), phosphorus, fat, and other minerals. A preferred source of vitamin D activity is cholecalciferol, and a preferred osteoblast stimulant is ipriflavone. In addition to these basic ingredients, the composition can further include various other minerals known to occur in bone, vitamin C, and glucosamine sulfate, all of which exert beneficial effects on growth and maintenance of healthy bone. A method for benefitting human bone health involves administering a daily regimen of the dietary supplement.

Devices and methods to heat and cool human beings, including inducing and maintaining hypothermia in human patients. Methods include inducing hypothermia to treat ischemic events, including heart attack and stroke, to limit damage caused by the ischemic event. Methods can include: using the lungs for heat exchange; using cooled gases for ventilation; using helium in the ventilation gas mixture, using medications to control reflex heat production; and injecting a perfluorocarbon mist into the gas stream to increase the cooling rate. The high thermal conductivity and diffusivity of helium results in greater inspired gas temperature equalization toward body temperature. Due to the latent heat of vaporization, addition of even small quantity of phase-change perfluorocarbon dramatically increases the heat carrying capacity of the respiratory gases. Hypothermia may be terminated by discontinuing the medications and warming the patient using a warmed helium-oxygen mixture.

A vertical cavity surface emitting laser device includes a first reflective mirror layer, a second reflective-mirror layer, and an active layer disposed therebetween, wherein at least one of the first reflective mirror layer and the second reflective mirror layer includes a periodic-refractive-index structure in which the refractive index periodically changes in the in-plane direction and a part of the periodic-refractive-index structure includes a plurality of parts that disorder the periodicity.

Method and neuroprosthetic device for monitoring and suppression of pathological tremors in a user through the neurostimulation of the afferent pathways to the brain, which comprises wearable elements placed over the parts of the body affected by tremor, wherein said wearable elements (1) have sensors selected from bioelectric sensors (3) generating a bioelectrical signal characterization of tremor, biomechanical sensors (4) generating a biomechanical signal characterization of tremor and a combination thereof, a programmable electronic device (9) comprised of a control, acquisition and processing module of the characterization signals, and a signal generator for the afferent stimulation based on the bioelectrical, biomechanical or combination of both signal characterization and stimulation electrodes (8) which transmit the neuromodulation signals to the afferent pathways projecting into the central nervous system to modulate the activity of the neural structures responsible for tremor generation.

A method is described for cancer treatment through NFκB inhibition. NFκB is a direct or ultimate target for small molecule inhibitors. These small molecule inhibitors are aimed at suppression of NFκB directly or by indirect suppression of IKK, SFK kinases, or other upstream kinases. The present invention includes small molecule inhibitors comprising three, five, and seven carbon unsaturated spacers having one or two carbonyls, flanked by substituted aryl rings. The small molecule inhibitors can be symmetrical or unsymmetrical.

Quinoxaline compounds, compositions, methods of making them, and methods of using them in leukocyte recruitment inhibition, in modulating an H₄ receptor, and in treating conditions such as inflammation, H₄ receptor-mediated conditions, and related conditions.

A lithium secondary battery includes: an electrode body having a positive electrode, a negative electrode, and a separator, the positive electrode and the negative electrode being wound or laminated by means of the separator; and a nonaqueous electrolyte solution containing a lithium compound as a electrolyte. At least one of the positive electrode, the negative electrode, the separator, the nonaqueous electrolyte solution contains at least one of: (a) an organic and/or inorganic inhibitor, which functions as a Cu-corrosion inhibitor or a Cu-trapping agent, (b) a compound having an organic base and an inorganic acid which are unitarily combined in a molecule, (c) a cyclic compound containing a N-O radical in a molecular structure, (d) a cyclic compound which becomes a Mn<2+> supplier in the nonaqueous electrolyte solution, (e) a compound containing an atom showing Lewis acidity and an atom showing Lewis basisity in one molecule, (f) a three-dimensional siloxane compound, and (g) a nonionic surfactant; or the nonaqueous electrolyte solution contains: (h) a water-extracting agent, or (i) a hydrofluoric acid-extracting agent. This lithium secondary battery exhibits an excellent effect that self-discharge property, cycle characteristics, long period stability and reliability can be planned.

A lithium battery includes a substrate, a positive electrode layer, a negative electrode layer, and a sulfide solid electrolyte layer disposed between the positive electrode layer and the negative electrode layer, the positive electrode layer, the negative electrode layer, and the sulfide solid electrolyte layer being provided on the substrate. In this lithium battery, the positive electrode layer is formed by a vapor-phase deposition method, and a buffer layer that suppresses nonuniformity of distribution of lithium ions near the interface between the positive electrode layer and the sulfide solid electrolyte layer is provided between the positive electrode layer and the sulfide solid electrolyte layer. As the buffer layer, a lithium-ion conductive oxide, in particular, Li_xLa_(2-x)/3TiO₃ (x=0.1 to 0.5), Li_7+xLa₃Zr₂O_12+(x/2) (−5≦×≦3, preferably −2≦×≦2), or LiNbO₃ is preferably used.

A shower head structure characterized by comprising a shower head section, opposed to the upper surface of a mounting table in an evacuable treating vessel, for injecting a processing gas into the treating vessel; a temperature observation through-hole which opens in the lower surface of the shower head so as to be opposed to the upper surface of the mounting table, a transparent observation window which hermetically seals the upper end of the temperature observation through-hole, a radiation thermometer disposed on the upper surface of the transparent observation window, an adhesion preventive gas supply path communicating with the temperature observation through-hole to prevent a film from adhering to the transparent observation window, wherein the adhesion preventive gas supply path communicates with the temperature observation through-hole through an injection nozzle for injecting the adhesion preventive gas to the transparent observation window.

A process liquid supply mechanism for supplying a process liquid comprises a process liquid supply source for supplying a process liquid, a process liquid discharging nozzle for discharging the process liquid, a pipe connecting the process liquid supply source to the process liquid discharging nozzle, a pump mounted to the pipe for allowing the process liquid to be discharged from the process liquid discharging nozzle, a pressure sensor for detecting the pressure of the process liquid at a prescribed position intermediate between the pump and the process liquid discharging nozzle, and a controller for controlling the inner pressure of the pump based on the pressure value detected by the pressure sensor and the relationship obtained in advance between the pressure and the discharging rate of the process liquid such that the process liquid is discharged at a prescribed discharging rate.

The present invention relates to a hormonal contraceptive product having two hormonal components, an estrogen and a gestagen, and a method for the continuous suppression of the menstrual cycle by uninterrupted administration of the product of the invention.

An organic light-emitting display (OLED) device includes: a lower substrate; an organic light-emitting element disposed on the lower substrate; an anti-oxidation layer covering the organic light-emitting element; an inorganic oxide encapsulation layer covering the anti-oxidation layer; a first organic layer covering the inorganic oxide encapsulation layer; and a first inorganic encapsulation layer covering the first organic layer. The anti-oxidation layer is configured to suppress the organic light-emitting element from being oxidized by oxygen (O₂) plasma at least in a pixel area.

In a vehicle dynamics control apparatus capable of balancing a vehicle dynamics stability control system and a lane deviation prevention control system, a cooperative control section is provided to make a cooperative control between lane deviation prevention control (LDP) and vehicle dynamics stability control (VDC). When a direction of yawing motion created by LDP control is opposite to a direction of yawing motion created by VDC control, the cooperative control section puts a higher priority on VDC control rather than LDP control. Conversely when the direction of yawing motion created by LDP control is identical to the direction of yawing motion created by VDC control, a higher one of the LDP desired yaw moment and the VDC desired yaw moment is selected as a final desired yaw moment, to prevent over-control, while keeping the effects obtained by both of VDC control and LDP control.

A composition for the treatment, prevention or management of a condition in primates, especially humans comprising a phenolic antioxidant-chromium complex.

An avalanche photodiode detector is provided with a substrate including an array of avalanche photodiodes. An optical interface surface of the substrate is arranged for accepting external input radiation. There is provided at least one cross-talk blocking layer of material including apertures positioned to allow external input radiation to reach photodiodes and including material regions positioned for attenuating radiation in the substrate that is produced by photodiodes in the array. Alternatively at least one cross-talk blocking layer of material is disposed on the optical interface surface of the substrate to allow external input radiation to reach photodiodes and attenuate radiation in the substrate that is produced by photodiodes in the array. At least one cross-talk filter layer of material can be disposed in the substrate adjacent to the photodiode structures, including a material that absorbs radiation in the substrate that is produced by photodiodes in the array.